Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $15.0 million.

  • Bristol Myers Squibb's Gains from Investment Securities fell 4827.59% to $15.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $341.0 million, marking a year-over-year increase of 558333.33%. This contributed to the annual value of $351.0 million for FY2025, which is 47340.43% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Gains from Investment Securities is $15.0 million, which was down 4827.59% from $336.0 million recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Gains from Investment Securities registered a high of $336.0 million during Q2 2025, and its lowest value of -$510.0 million during Q1 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$23.0 million (2024), whereas its average is -$61.2 million.
  • The largest annual percentage gain for Bristol Myers Squibb's Gains from Investment Securities in the last 5 years was 17250.0% (2024), contrasted with its biggest fall of 47500.0% (2024).
  • Bristol Myers Squibb's Gains from Investment Securities (Quarter) stood at -$32.0 million in 2021, then plummeted by 37.5% to -$44.0 million in 2022, then rose by 9.09% to -$40.0 million in 2023, then soared by 172.5% to $29.0 million in 2024, then tumbled by 48.28% to $15.0 million in 2025.
  • Its Gains from Investment Securities stands at $15.0 million for Q4 2025, versus $336.0 million for Q2 2025 and -$10.0 million for Q1 2025.